The Korean National Assembly Health and Welfare Committee member Rep. Jeon Jin-suk (Democratic Party) highlighted that recent legislative reforms targeting the management of medical narcotics prescriptions are yielding tangible results on the ground. In the 2024 national audit, she pointed out weaknesses in the existing system, noting that some patients were obtaining repeated narcotic prescriptions by visiting multiple healthcare facilities.
Following amendments to the relevant law, data show that the number of medical professionals who received information for violating narcotics misuse control criteria decreased in most drug categories in 2026 compared with 2025. Rep. Jeon attributed this decline to the strengthened regulatory framework introduced after the 2024 Food and Drug Safety Ministry audit.
The findings suggest that the new measures are effective in curbing the over‑prescription and potential abuse of controlled substances within the Korean healthcare system.
Actualizaciones regulatorias31 ago 2026•1 min de lectura
Korean Lawmaker Reports Decrease in Medical Narcotics Misuse Cases After Legislative Reform
Legislative changes aimed at improving narcotics prescription management have led to a measurable drop in reported misuse cases among medical professionals in 2026, according to Rep. Jeon Jin-suk.
Recopilado por el equipo de PharmaCountry · Fuente: KPA News
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración